Clinical Trials on Advanced HCC in Sweden
Total 84 results
-
Region SkaneLund UniversityCompletedAdvanced ENT Surgery | Microbiological Flora in the Oropharynx and Lower AirwaysSweden
-
Novartis PharmaceuticalsTerminated
-
Vall d'Hebron Institute of OncologyTaisho Pharmaceutical Co., Ltd.; Roche Pharma AG; Iqvia Pty Ltd; Janssen, LPRecruitingAdvanced Solid TumorSpain, France, Germany, Netherlands, Sweden, United Kingdom, Italy
-
AstraZenecaActive, not recruitingBreast | Prostate | Ovarian | Pancreatic | Advanced TumoursSweden, Spain, Israel, Australia, Germany
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
Incyte CorporationActive, not recruitingAdvanced Solid TumorsUnited States, Sweden, Netherlands, Norway, Denmark
-
Lund University HospitalMerck Sharp & Dohme LLCCompletedLocally Advanced Cancer in the Anal RegionSweden, Norway
-
Lund University HospitalCompletedLocally Advanced Head and Neck CancerSweden
-
Abbott Medical DevicesThoratec Europe LtdCompletedAdvanced Heart Failure | CRT and/or ICDNetherlands, Sweden, Denmark, France, Germany, United Kingdom
-
BayerCompletedAdvanced Recurrent Malignant Pleural Epithelioid Mesothelioma | Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma | Advanced Recurrent Serous Ovarian Cancer | Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated)United States, Sweden, Netherlands, United Kingdom, Finland
-
Umeå UniversityKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsRecruitingQuality of Life | Surgery | Pancreas Adenocarcinoma | Chemotherapy Effect | Pancreas Cancer | Pancreas Neoplasm | Pancreas Disease | Locally Advanced Pancreatic Adenocarcinoma | Borderline Resectable Pancreatic AdenocarcinomaSweden
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsUnited States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
-
Novartis PharmaceuticalsCompletedcMET Dysegulation Advanced Solid TumorsAustria, Denmark, Sweden, United Kingdom, Spain, Germany, Netherlands, United States
-
PfizerTerminatedEarly Breast Cancer (Phase 2) | Advanced Breast Cancer (Phase 1b)Spain, Sweden, Italy, Belgium
-
Karolinska InstitutetSkane University HospitalActive, not recruitingAdvanced Ovarian CancerSweden
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedAdvanced Breast CancerSouth Africa, Sweden, Hungary, Taiwan, Spain
-
Ass. Prof. Jan NymanTerminatedNon Small Cell Lung Cancer | Locally Advanced DiseaseSweden
-
Azienda Ospedaliera di PerugiaNot yet recruitingAdvanced Melanoma | Early MelanomaItaly, Sweden, France, Germany, Netherlands, Poland, Spain
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
Bristol-Myers SquibbCompletedHepato Cellular Carcinoma (HCC)United States, Argentina, Australia, Belgium, Brazil, Canada, China, Czech Republic, France, Germany, Hong Kong, India, Italy, Japan, Korea, Republic of, Mexico, Poland, Puerto Rico, Russian Federation, South Africa, Spain, Sweden, ... and more
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast CancerFrance, Italy, Germany, Singapore, Sweden, Spain, United Kingdom, United States
-
Bristol-Myers SquibbCompletedVarious Advanced CancerUnited States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, United Kingdom
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Australia, Canada, Chile, China, France, Greece, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Sweden
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
-
AIO-Studien-gGmbHServier Deutschland GmbH; Crolll GmbhActive, not recruitingMetastatic Pancreatic Cancer | Locally Advanced Pancreatic CancerGermany
-
Merck Sharp & Dohme LLCCompletedHCV InfectionUnited States, Germany, Poland, Sweden
-
European Organisation for Research and Treatment...CompletedColorectal Cancer | Advanced Colorectal CancerBelgium, Switzerland, Poland, Spain, France, Italy, Germany, Cyprus, Greece, Portugal, Sweden
-
BayerCompletedCarcinoma, Renal Cell | Carcinoma, Renal Cell (Advanced)Poland, China, Slovakia, France, Germany, Indonesia, Korea, Republic of, Sweden, Philippines, Austria, Colombia, Czech Republic, Mexico, Russian Federation, Slovenia, Argentina, Greece, Netherlands
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingVarious Advanced CancerUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, Greece, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Peru, Poland, Romania, Russian Federation and more
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Malignant Solid TumorsUnited States, Taiwan, United Kingdom, Hong Kong, Belgium, France, Spain, China, Netherlands, Poland, Sweden
-
Merck Sharp & Dohme LLCEisai Inc.CompletedAdvanced MelanomaCanada, United States, Australia, Spain, Sweden
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedVarious Advanced CancerUnited States, Czechia, Japan, Poland, Australia, Belgium, Finland, Germany, Italy, Spain, Sweden
-
AstraZenecaRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedCytomegalovirus (CMV)-Positive Recipients | Allogeneic, Hematopoietic Cell Transplant (HCT)Japan, Korea, Republic of, United States, Canada, Australia, Belgium, France, Germany, Spain, Sweden, Taiwan
-
Eli Lilly and CompanyCompletedHistological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy.Hungary, Germany, Austria, Spain, Sweden
-
Jurgen BarthCompletedHairy Cell Leukemia (HCL)Germany
-
AIO-Studien-gGmbHBristol-Myers SquibbActive, not recruitingTransitional Cell Carcinoma | Metastatic Cancer | Advanced CancerGermany, Austria
-
Egetis TherapeuticsPharma Consulting Group ABCompletedAdvanced Metastatic (Stage IV) Colorectal CancerSweden, United States, Bulgaria, Denmark, Georgia, Germany, Portugal, Serbia
-
Novartis PharmaceuticalsCompletedAdvanced Breast CancerBelgium, Italy, Czechia, Hungary, Canada, Netherlands, Germany, Singapore, Australia, Denmark, Poland, Switzerland, Korea, Republic of, Spain, Thailand, Lebanon, Austria, Bulgaria, Russian Federation, Norway, Jordan, United States, ... and more
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.Italy, Spain, United Kingdom, Sweden, Japan, Netherlands, Germany, France
-
Novartis PharmaceuticalsRecruitingMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal CancersJapan, Italy, Spain, Singapore, Belgium, Germany, Korea, Republic of, Sweden, Taiwan, France, Israel, Norway, United States
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesItaly, Spain, United States, Korea, Republic of, Turkey, Taiwan, Sweden, Czechia, United Kingdom
-
CellCentric Ltd.RecruitingAdvanced Solid Tumors | Metastatic Breast Cancer | Non-small Cell Lung Cancer | Metastatic Castration-Resistant Prostate CancerUnited Kingdom, United States, Netherlands, France, Spain, Sweden
-
iOMEDICO AGRoche Pharma AGCompletedExtensive-stage Small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBCGermany
-
Novartis PharmaceuticalsCompletedAdvanced Neuroendocrine Tumors of Pancreatic OriginCanada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditionsFinland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesUnited States, Spain, Belgium, France, Germany, Italy, Korea, Republic of, Turkey, Hungary, Netherlands, Serbia, Poland, Russian Federation, Sweden, Moldova, Republic of, Denmark, Ukraine